Pharsight

TEVA PHARMACEUTICALS PATENTS FACING OPPOSITIONS

Top patents of TEVA PHARMACEUTICALS facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3344607B1 06 Nov, 2019 Solid state forms of selexipag NA 2
EP3045182B1 07 Mar, 2018 Antagonist antibodies directed against calcitonin gene-related peptide for treating cluster headache Nov, 2026 2
EP2688877B1 Solid state forms of cabazitaxel and processes for preparation thereof NA 1
EP3497104B1 06 Oct, 2021 Solid state forms of lumateperone ditosylate salt NA 1